• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1137


Intended Use: Intended to be used at levels ranging from 0.01 to 0.8% on a protein basis to improve the perception of sweetness of white granulated sugar.
Basis: Scientific procedures
Notifier: Incredo Ltd.
Notifier Address: 9 Shimson Street
Petach-Tikva 49517
GRAS Notice (releasable information): GRN 1137 with amendments (in PDF) (8.9 MB)
Date of closure: Jan 19, 2024
FDA's Letter: FDA has no questions (in PDF) (188 kB)